2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Testosterone cyclopentylpropionate: new trials by email Literature Review of Testosterone cyclopentylpropionate trials Research Report on Testosterone cyclopentylpropionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers. Bupropion, Anastrozole, Testosterone cyclopentylpropionate - Healthy Volunteers | Phase 1 | Completed | Parc de Salut Mar | 9 | 2020-12-03 | 2021-04-26 |
| Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer Laboratory Biomarker Analysis, Olaparib, Quality-of-Life Assessment - Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Completed | University of Washington | 36 | 2018-08-29 | 2025-09-29 |
Parc de Salut Mar (1) · University of Washington (1)
Spain (1) · United States (1)
Ana M Aldea Perona, MD PhD (1) · Michael T. Schweizer (1)
P30CA015704 (1)